1. Home
  2. CPBI vs GANX Comparison

CPBI vs GANX Comparison

Compare CPBI & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPBI
  • GANX
  • Stock Information
  • Founded
  • CPBI 2023
  • GANX 2017
  • Country
  • CPBI United States
  • GANX United States
  • Employees
  • CPBI N/A
  • GANX N/A
  • Industry
  • CPBI
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPBI
  • GANX Health Care
  • Exchange
  • CPBI Nasdaq
  • GANX Nasdaq
  • Market Cap
  • CPBI 56.9M
  • GANX 53.8M
  • IPO Year
  • CPBI N/A
  • GANX 2021
  • Fundamental
  • Price
  • CPBI $15.05
  • GANX $1.57
  • Analyst Decision
  • CPBI
  • GANX Strong Buy
  • Analyst Count
  • CPBI 0
  • GANX 5
  • Target Price
  • CPBI N/A
  • GANX $8.20
  • AVG Volume (30 Days)
  • CPBI 4.5K
  • GANX 317.3K
  • Earning Date
  • CPBI 01-01-0001
  • GANX 08-07-2025
  • Dividend Yield
  • CPBI N/A
  • GANX N/A
  • EPS Growth
  • CPBI N/A
  • GANX N/A
  • EPS
  • CPBI 0.96
  • GANX N/A
  • Revenue
  • CPBI $18,899,000.00
  • GANX N/A
  • Revenue This Year
  • CPBI N/A
  • GANX N/A
  • Revenue Next Year
  • CPBI N/A
  • GANX N/A
  • P/E Ratio
  • CPBI $15.79
  • GANX N/A
  • Revenue Growth
  • CPBI 9.64
  • GANX N/A
  • 52 Week Low
  • CPBI $10.09
  • GANX $0.89
  • 52 Week High
  • CPBI $15.50
  • GANX $3.19
  • Technical
  • Relative Strength Index (RSI)
  • CPBI 46.81
  • GANX 38.81
  • Support Level
  • CPBI $14.88
  • GANX $1.65
  • Resistance Level
  • CPBI $14.99
  • GANX $2.04
  • Average True Range (ATR)
  • CPBI 0.13
  • GANX 0.16
  • MACD
  • CPBI -0.00
  • GANX -0.00
  • Stochastic Oscillator
  • CPBI 8.57
  • GANX 11.36

About CPBI Central Plains Bancshares Inc.

Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: